aod9604 clinical trial results BioWorld You’re Injecting AOD-9604 WRONG! Doctor
Description
What researchers did find was that weight loss was consistently reported as a side effect in overweight or obese patients
Want to read more
It was found through preliminary research that treatment with AOD9604 over the course of 14 days in obese mice led to decreased body weight and body fat and was shown to increase the activity of the beta(3)-adrenergic receptors in the fat cells to the same level as those in lean mice
To sum up, some patients report the worsening of symptoms within the first few days or weeks when they begin B12 shots
Inflammation in the GI tract often leads to lower stomach acid which impairs the absorption of B12
Purging and Temporary Shedding The most distressing side effect is temporary increased shedding
